Medicine

siRNA treatment reduces triglycerides in patients with rare condition

.INVESTIGATION EMPHASIZE.19 September 2024.

Plozasiran reduced triglyceride levels by 80% as well as reduced the threat of pancreatitis in people along with persistent chylomicronemia, with or even without a genetic prognosis.

Articles You Can Be Interested In